Clodavan

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clodavan

Quick Facts

Property Description
Active Ingredient Clobetasol Propionate
Form Topical preparations (Cream, Ointment, Gel, Solution, etc.)
Pharmacological Class Super-high Potency Corticosteroid (Group I)
Common Use (General) Relief of severe inflammatory and pruritic skin manifestations
Origin Synthetic (Fluorinated Corticosteroid)

What Type of Drug is Clodavan? (Classification and Identity)

Clodavan is a prescription-only dermatological drug defined by its active component, clobetasol propionate. This substance is a synthetic fluorinated corticosteroid, chemically engineered for enhanced biological activity. The drug is classified as a Super-high Potency Corticosteroid (Class I), placing it in the highest strength category available among topical agents. This extreme potency is clinically recognized for its capacity to address skin conditions that have failed to respond adequately to lower-potency steroids.

Composition and Topical Preparations

The medication is a single-ingredient product, containing only clobetasol propionate, compounded within specialized dermatological bases to ensure effective delivery. Clodavan is manufactured exclusively for topical dermatologic use, necessitating its application directly to the skin surface. It is available in diverse dosage form(s)—including cream, ointment, gel, lotion, or solution—allowing the specific vehicle base to be selected to optimize absorption for the affected skin area.

General Therapeutic Purpose

The general therapeutic purpose of Clodavan is to provide rapid and intense symptomatic relief. Clobetasol propionate exerts powerful anti-inflammatory and antipruritic (anti-itch) effects. This drug works by activating natural substances in the skin to reduce swelling, redness, and itching. The scientific consensus supports the use of this high-potency agent for quickly managing intense inflammatory manifestations and associated discomforts related to highly active corticosteroid-responsive dermatoses.

Regulatory References

  1. Topical Corticosteroids Classification (NIH/DailyMed)

What side effects are possible with Clodavan?

Possible Side Effects and Safety Information

The safety profile of Clodavan, which contains the super-high potency corticosteroid clobetasol propionate, is primarily characterized by local skin reactions and a documented risk of systemic adverse reactions due to percutaneous absorption, as noted in official regulatory labeling.


Adverse Reaction Classifications

The most frequently documented side effects are common application site reactions, including burning, stinging, and pain at the area of use. Other local skin changes are classified as uncommon and are often associated with prolonged use; these include skin atrophy (thinning), striae (stretch marks), telangiectasia (spider veins), and hypopigmentation.

Serious adverse reactions, though rare, relate to the systemic absorption of the potent steroid. These include the potential for Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and manifestations of Cushing's syndrome, classified under Endocrine Disorders. The risk of developing conditions like glaucoma or cataracts is also documented under Ophthalmic Disorders.


Duration, Exposure, and Population Safety

Official safety information states that the risk of systemic effects and irreversible local changes significantly increases with long-term use, application over large body surface areas, or use under occlusive dressings. Certain populations are explicitly noted as being more susceptible to systemic toxicity; for instance, pediatric patients are at a heightened risk for adverse effects, including HPA axis suppression and intracranial hypertension.

Regulatory documents also detail safety-related constraints, noting that the medication is contraindicated for use in conditions like rosacea or perioral dermatitis and should generally be avoided on highly sensitive areas such as the face, groin, or armpits.

Overdose and Emergency Response

Clodavan Overdose and When to Seek Help

An overdose of Clodavan (which contains clonazepam, a benzodiazepine) primarily leads to an exaggeration of the drug’s intended effects, which are central nervous system (CNS) depressant actions. While an overdose of Clodavan alone is rarely life-threatening, combining it with other CNS depressants, particularly alcohol or opioid medications, significantly increases the risk of serious complications, including fatal outcomes.

Symptoms of Overdose

Symptoms can range from mild to severe, typically appearing as pronounced sedation and impaired coordination. Severe toxicity may involve profound CNS depression.

Mild to Moderate Symptoms Severe Symptoms (Medical Emergency)
Excessive drowsiness/somnolence Dangerously slow or shallow breathing (respiratory depression)
Mental confusion, slurred speech Loss of consciousness or coma
Impaired coordination, unsteadiness, ataxia Bradycardia (slow heart rate)
Diminished reflexes Apnea (stopped breathing)

When to Seek Help

Immediately contact emergency medical services (e.g., call 911 or the poison control center) if you or someone else experiences any of the severe symptoms listed above after taking Clodavan, or if a known overdose has occurred. Immediate supportive medical care, which may include airway management, is the mainstay of treatment. It is crucial to be honest with emergency responders about what was taken, including any other substances, to ensure appropriate and timely treatment.

Therapeutic Uses of Clodavan

What Clodavan Treats: Main Uses and Benefits

Clodavan is commonly used for the management of severe inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, including conditions such as plaque psoriasis, recalcitrant eczema (atopic dermatitis), and lichen planus. The primary therapeutic domain is the relief of these intense manifestations in patients requiring a super-high potency topical agent. It is applied in clinical settings marked by heightened symptoms where other less potent topical treatments have generally failed to provide satisfactory relief. The primary benefit is to offer supportive relief during periods of heightened symptoms and to support a reduction in the disruptive physical manifestations of these diseases.

The medication targets symptom clusters that may become intense or disruptive, focusing primarily on severe, persistent itching (pruritus) and the pronounced redness and swelling that define active inflammation. Clodavan is relevant for managing symptoms related to chronic thickening and scaling often linked to these conditions. It provides symptomatic relief that supports patients during difficult episodes and contributes to easing the overall symptom load during periods of heightened symptoms.

This medication is relevant in clinical situations where localized skin lesions, such as those on the elbows, knees, palms, or scalp, are particularly resistant to treatment or require enhanced drug penetration due to skin thickness. It is often used when symptoms intensify and supportive relief is needed, contributing to temporary assistance in symptom stabilization of the inflammatory component of the disease. It provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Severe Inflammation and Itching

Symptom Type Examples of Supportive Relief
Inflammatory Moderation of pronounced redness and swelling
Pruritic Supportive relief from severe, persistent itching
Chronic Easing of skin thickening and scaling

Regulatory References

  1. NIH DailyMed Labeling Information

Eligibility and Restrictions for Use

Who can and cannot use Clodavan?

The population eligibility for Clodavan (Clobetasol Propionate) is strictly defined by regulatory documents due to the drug’s super-high potency, with several absolute contraindications and restrictions.

Absolute Prohibitions

The medicine is contraindicated for patients with a known hypersensitivity to the active substance or excipients. It must not be used to treat specific skin conditions, including rosacea, perioral dermatitis, acne vulgaris, and untreated primary cutaneous infections. Regulatory labeling also restricts application on the face, groin, and axillae.

Age and Physiological Status

Use is strictly contraindicated in children under one year of age. Furthermore, use is not recommended for children under 12 years, as safety and effectiveness have not been established, and they face a greater risk of systemic toxicity. For older adults and patients with decreased hepatic or renal function, caution is advised if systemic absorption is a concern.

Pregnancy and Lactation

In pregnancy, Clodavan is classified as Category C (FDA). Use is permitted only if the potential benefit justifies the potential risk to the fetus. Caution should be exercised during lactation, and the product must not be applied to the breast area.

What should I know about interactions with other medicines?

Clodavan Interactions with Other Medicines and Products

This section outlines the officially documented interaction profile of Clodavan (clobetasol propionate), based strictly on government regulatory documents.


The primary interaction concern for this super-high potency topical corticosteroid is the potential for increased systemic exposure due to alterations in drug metabolism. Factors that may increase systemic absorption and delay clearance must be considered.

Documented Pharmacokinetic Interactions

Interaction Type Interacting Substances Regulatory Description
Metabolic Inhibition Potent CYP3A4 Inhibitors (e.g., Ritonavir, Itraconazole) These agents inhibit the primary enzyme (CYP3A4) responsible for corticosteroid metabolism, potentially leading to increased systemic drug levels.
Additive Effect Other Corticosteroid-Containing Preparations Concurrent use may result in an additive systemic effect, increasing the overall potential for corticosteroid-related systemic effects.

Population-Specific Interaction Notes

  • Hepatic Impairment (Liver Failure): Patients with impaired liver function may experience delayed elimination of the drug if systemic absorption occurs, which increases the risk of systemic effects.
  • Elderly Patients: Due to the more frequent decrease in hepatic or renal function in this population, the potential for delayed elimination upon systemic absorption is noted in regulatory information.

Regulatory documents do not classify any specific medicinal product combinations as formally contraindicated due to a drug-drug interaction mechanism. Furthermore, there are no documented timing-separation requirements or established interactions with food, alcohol, or herbal products.

Mechanism of Action

How Clodavan Works

The mechanism of clobetasol propionate is defined by its selective agonism at the Glucocorticoid Receptor ( GR), the primary intracellular target. Upon binding, the activated drug-receptor complex translocates to the cell nucleus, where it initiates genomic modulation. This process involves upregulation (Transactivation) of genes for anti-inflammatory proteins, such as Lipocortin-1, and downregulation (Transrepression) of genes for pro-inflammatory transcription factors, including NF- Kappa B.

This modulation results in a critical downstream cascade: the indirect inhibition of the enzyme Phospholipase A2 ( PLA2). By restricting PLA2 activity, the drug curtails the synthesis of eicosanoid mediators like prostaglandins and leukotrienes, thereby suppressing the primary chemical signals that drive local hyperthermia and edema. Concurrently, the drug exerts a rapid peripheral action by inducing localized vasoconstriction and modulating the function and migration of immune cells, reducing tissue fluid accumulation and local immunocyte activity.

Dosage and Administration Information

Clodavan (clobetasol propionate ophthalmic suspension) must be used strictly according to the established instructions for administration following ocular surgery.

Administration scope

Instruction Category Requirement (Clobetasol Propionate 0.05% Ophthalmic Suspension)
Route of Administration Ophthalmic (affected eye only).
Dosing Rules Instill one drop of the suspension.
Frequency and Timing Twice daily (BID). The start date must be the day after surgery, and use must continue throughout the first two weeks of the post-operative period.
Preparation Steps Wash hands well before each use.
Special Conditions Do not instill while wearing contact lenses; they must be removed prior to instillation. If other eye drops are used, wait at least five minutes between the instillation of Clodavan and other drops.
Age-Specific Use Safety and efficacy have not been established in pediatric patients.
Missed Dose Instructions for a missed dose are not explicitly documented in the established dosage guidelines.

Connection to the overall use protocol

The procedural structure defines a precise, short-duration course of treatment for the post-operative period. The administration involves a simple one-drop, twice-daily regimen for the initial two weeks following surgery. Compliance with hand washing, contact lens removal, and spacing out other ophthalmic agents is required to maintain product integrity and ensure proper drug delivery.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Clodavan

Research has examined Clodavan's component in adults with conditions characterized by fluctuating or episodic manifestations, such as moderate-to-severe plaque psoriasis. Research includes numerous short-term, randomized controlled trials (RCTs), many of which were designed as double-blind studies and included comparison against a vehicle or other treatments. These studies were applied in research contexts involving unstable symptoms.

Research reports on measurements taken over just a few weeks related to the visible signs of the condition and patient-reported outcomes describing discomfort. The component was evaluated in studies exploring its role in other corticosteroid-responsive dermatoses, including Lichen Planus and recalcitrant eczema. Research describes patterns observed in how symptoms evolved during the study period, focusing on outcomes linked to inflammatory or irritative states.

A primary research limitation frame is that follow-up durations were limited across the core efficacy trials, meaning the sustainability of observed patterns and long-term outcomes is not fully established. Data for certain groups remain insufficient, particularly in pediatric subjects, and subgroup findings are uncertain. Comparative evidence is also lacking in some areas, leading to the conclusion that certainty remains low for some long-term aspects of treatment. Findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Label: CLOBETASOL PROPIONATE cream (DailyMed/FDA monograph on super-high potency classification, indications, and usage limitations)
  2. Topical Corticosteroids - StatPearls (NCBI Bookshelf/NIH review on potency classes, vehicles, and use in eczema/psoriasis)

Frequently Asked Questions (FAQ)

Common questions about Clodavan (FAQ)


Q: What happens if I miss a scheduled application of Clodavan?

The product information states that an application can be made as soon as the missed application is recalled. However, if it is almost time for the next scheduled application, the missed dose should be skipped to return to the regular schedule. The product labeling specifies that double or extra applications should not be made to compensate for a missed one.


Q: Is it normal to feel a mild burning or stinging when I first apply Clodavan?

Yes, regulatory documents indicate that common side effects include burning and stinging at the site of application. These local application site reactions are frequently reported. In most cases, these sensations tend to decrease after the first few days of using the product.


Q: Can Clodavan affect blood sugar levels, especially for people with diabetes?

Topical steroids like Clodavan can be absorbed through the skin, which carries a potential, though rare, risk of affecting systemic body functions. This includes the possibility of raising blood glucose levels in some individuals by affecting how the body manages insulin. Official information advises that caution is necessary for patients with diabetes or a predisposition to high blood sugar.


Q: What if my skin condition clears up before the recommended treatment time for Clodavan is over?

The official instruction is that use of the medication should be discontinued once the treated condition has been controlled. This high-potency product is intended for short courses of treatment and should not be used beyond the duration prescribed in the official directions.


Q: How should Clodavan be applied to the scalp for conditions like psoriasis?

Specific application details, such as use on a dry scalp for a set duration before rinsing, are provided in the product's official dosing instructions for that form. This ensures proper product delivery and prevents excessive absorption. Other forms like the solution or foam are generally applied to the affected area and rubbed in gently, following the exact package directions.


Q: What are the signs of a skin infection getting worse while using Clodavan?

Official warnings state that if your condition does not improve quickly, or if signs of a skin infection appear to worsen or are not adequately controlled, the medication should be discontinued. This action is necessary so that appropriate therapy for the infection can be started without further delay.


Q: Can Clodavan cause a headache or dizziness?

Dizziness is noted in some adverse reaction reports as a potential symptom of a more serious, though rare, systemic effect such as adrenal insufficiency. Headache is also sometimes associated with rare side effects like increased pressure within the skull. If concerning symptoms, such as a persistent or severe headache or dizziness, are experienced, consulting with a healthcare professional is appropriate.


Q: What is the experience of people who stop Clodavan after long-term use (topical steroid withdrawal)?

Official regulatory reviews acknowledge that withdrawal reactions have been reported, especially after long-term or excessive use of potent topical steroids. Symptoms can include severe redness, burning, stinging, and itching that may be worse than the original condition. Official regulatory reviews note that for prolonged use, gradual reduction in strength or frequency is a commonly documented strategy to help mitigate these reactions.


Q: Can I use my regular shampoo immediately after rinsing out Clodavan shampoo?

Yes, patient information for the shampoo formulation indicates that after thoroughly rinsing out the medicated shampoo, a nonmedicated shampoo may be used immediately if desired.


Q: What is the relationship between Clodavan and adrenal gland function?

Because Clodavan is a high-potency steroid and can be absorbed through the skin, it carries a potential risk of temporarily suppressing the function of the Hypothalamic-Pituitary-Adrenal (HPA) axis). This is the system responsible for regulating the body’s natural steroid production. This risk is greater with prolonged use or application over large body areas.


Q: Why is Clodavan not recommended for diaper rash in infants?

Use of this medication is not recommended for diaper rash primarily due to the increased risk of systemic absorption in infants. Using tight-fitting diapers or plastic pants essentially creates an occlusive dressing, which can significantly boost the amount of potent steroid absorbed into the infant’s system, thereby increasing the risk of systemic side effects.


Q: What is the maximum amount of Clodavan shampoo that can be used per week?

Regulatory documents state that due to the risk of systemic absorption and HPA axis suppression, the total dosage of Clodavan preparations should not exceed 50 grams (or 50 mL for liquid forms) per week.


Q: Can Clodavan interfere with the effectiveness of latex condoms or diaphragms?

Official patient information for some formulations of Clodavan advises that the product should not come into contact with latex-containing products. This is because certain ingredients, particularly those found in the vehicle bases, may potentially damage the latex and compromise the integrity of devices such as condoms or diaphragms.


Q: Does Clodavan treat the cause of psoriasis, or just the symptoms?

Clodavan is classified as an anti-inflammatory and anti-itch agent. Its purpose is to provide relief from the inflammatory and pruritic (itching) manifestations of certain skin conditions. It works by suppressing the body's inflammatory response, meaning it manages the symptoms rather than addressing the underlying, long-term cause of diseases like psoriasis.


Q: What kind of studies have been done on the safety of Clodavan in adolescents?

Safety and effectiveness have not been fully established in children under 12 years of age, and use in this group is generally not recommended due to a higher risk of systemic side effects. For adolescents (ages 12 to 18), use may be permitted depending on the specific product form and the clinical judgment of a healthcare provider, but studies in this age group may be limited.


Q: Is there any research on the effectiveness of Clodavan for conditions other than psoriasis and eczema?

The drug is indicated for a range of corticosteroid-responsive dermatoses. Beyond psoriasis and eczema, clinical trials and official product labeling have also explored and confirmed its effectiveness in short-term studies for other conditions, such as Lichen Planus.


Q: What is a 'fingertip unit' and how does it relate to measuring Clodavan cream/ointment?

The fingertip unit (FTU) is a standardized, simple measure used to estimate the correct amount of topical medication. An FTU is defined as the amount of cream or ointment squeezed onto the length of an adult's finger from the tip to the first crease. This amount is generally considered adequate to cover an area equivalent to twice the size of the flat of an adult's hand.


Q: How can I tell the difference between a common side effect and a serious reaction to Clodavan?

It is important to be aware of the signs of rare, but serious systemic side effects, such as signs of adrenal gland problems (extreme tiredness, changes in appetite) or high blood sugar (increased thirst or urination). Any concerning symptoms should be reported, especially if they are severe or continue after the drug is stopped, to distinguish them from common, mild application site reactions.


Q: Is it safe to use Clodavan during pregnancy or while breastfeeding?

Official labeling places this drug in Pregnancy Category C. Use during pregnancy is permissible only if the potential benefit is judged to outweigh the potential risk to the fetus. Caution should also be exercised when the product is used while breastfeeding, and it must never be applied to the breast area.


Q: What should I do if Clodavan accidentally gets into my eyes?

Official warnings indicate that if accidental contact with the eye occurs, the affected eye should be immediately rinsed with a large volume of water.


Q: What are the general risks of using a super-high-potency topical steroid like Clodavan?

The general risks are related to its high potency and absorption potential. These include local adverse reactions (like skin thinning and stretch marks) and the potential for systemic adverse reactions (like HPA axis suppression and Cushing’s syndrome). These risks are documented in official safety information.


Q: Do I need to taper off Clodavan if I've been using it for a long time?

For prolonged use, reducing the strength or frequency of application gradually is a recommended practice noted in official guidance. This technique may help prevent potential side effects like a sudden return of symptoms (rebound flare) or a topical steroid withdrawal reaction.


Q: What specific skin conditions is Clodavan primarily used to treat?

Clodavan is a high-potency corticosteroid primarily used for the relief of severe inflammatory and pruritic (itchy) manifestations. It is indicated for certain corticosteroid-responsive dermatoses, including conditions like moderate-to-severe plaque psoriasis, Lichen Planus, and recalcitrant eczema.


Q: Is Clodavan available in different forms, such as cream, ointment, or shampoo?

The active ingredient in Clodavan is compounded into various topical preparations designed for different skin conditions and body areas. Available forms generally include cream, ointment, gel, lotion, solution, foam, and sometimes a shampoo formulation.


Q: How does Clodavan work to reduce skin inflammation and itching?

Clodavan works by activating natural substances within the skin cells to effectively reduce swelling, redness, and itching. The drug functions by suppressing the production of powerful pro-inflammatory chemical signals, which allows it to exert its strong anti-inflammatory and anti-itch effects.


Q: Do other topical products, like moisturizers, interact with Clodavan if applied at the same time?

Official drug interaction information focuses mainly on oral medications, but separation of topical products is a common precaution. To ensure the proper absorption and effectiveness of Clodavan, a waiting period, often five minutes or more, is generally recommended between the application of Clodavan and other topical products like moisturizers.


Q: Is Clodavan safe for use in children under 12 or 18 years old?

Use is strictly prohibited for children under one year of age. It is generally not recommended for children under 12, as safety and effectiveness have not been fully established, and they face a heightened risk of systemic side effects. For adolescents (12-18), use may be permitted depending on the specific product form and the clinical judgment of a healthcare provider.


Q: What are the less common, but more serious, potential side effects of Clodavan?

Serious adverse reactions relate to the systemic absorption of the potent steroid. These include the potential for Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and rare manifestations of Cushing's syndrome. Risks like glaucoma or cataracts are also documented under Ophthalmic Disorders.


Q: What is the difference between Clodavan shampoo and Clodavan cream/ointment in terms of use?

While all forms contain the same active ingredient, the specific vehicle base determines the use. Shampoos and solutions are typically designed for treating the scalp or hairy areas, while thicker creams and ointments are generally intended for use on patches of dry, scaly skin on the body.


Q: How does Clodavan compare to other mid-strength topical steroids like hydrocortisone?

Clodavan is officially classified as a Super-high Potency Corticosteroid (Class I), placing it in the highest strength category available. This makes it significantly more potent than mid-strength steroids, such as hydrocortisone, and it is reserved for severe conditions that have not responded adequately to lower-potency treatments.


Q: Does Clodavan need to be rubbed in completely, or just applied lightly?

Official directions often advise that the product should be applied lightly to the affected skin area. To ensure effective delivery and absorption of the medication, it should generally be applied with a gentle, brief rubbing motion, following the specific instructions on the product packaging.


Q: How long should I wait between applying Clodavan and another topical product like a moisturizer?

While specific skin application waiting periods are not universally mandated, separation is a general precaution. For ophthalmic use, official instructions require a waiting period of at least five minutes between the instillation of Clodavan and other eye drops to prevent wash-out, and a similar waiting period is often recommended for skin applications.


Q: What is the significance of Clodavan being a 'fluorinated' corticosteroid?

Clodavan's active component is classified as a synthetic fluorinated corticosteroid. The addition of fluorine to the chemical structure is a common modification used in pharmacology. This engineering is designed to enhance the drug's biological activity, which contributes directly to its classification as a highly effective, super-high potency topical agent.

How should Clodavan be stored and disposed of?

How to Store and Dispose of Clodavan?

Storage and disposal requirements for Clodavan are strictly defined in regulatory documents to ensure product stability and safety. The product must be stored at Controlled Room Temperature, typically 15 to 30 C (59 to 86 F), and must not be refrigerated. Keep the container tightly closed and protected from excess heat, light, and moisture.

Safety and Handling

It is a mandatory regulatory requirement to keep this and all medication out of the sight and reach of children.

Specific forms, such as the solution or foam, are officially designated as flammable; users must avoid fire, flame, or smoking during and immediately after application.

Official Disposal

Expired or unused Clodavan should not be disposed of in household trash or flushed down the toilet. Dispose of the product through an approved drug take-back program or as directed by a local waste disposal company to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Clodavan found in:

A-Z Index: